Literature DB >> 17317376

Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle.

Abdul Rahman K Doughan1, Michael E McConnell, Wendy M Book.   

Abstract

This study evaluated the effects of beta blockers (carvedilol and metoprolol XL) on New York Heart Association functional class and systemic right ventricular (RV) function in patients with complete transposition of the great arteries who had systemic RV dysfunction late after atrial inflow correction. A significant improvement in New York Heart Association functional class was found after 4 months of therapy with beta blockers. Functional recovery was significant mostly in those patients with pacemakers who received higher maintenance doses of carvedilol. RV end-diastolic area was significantly greater in untreated patients at the end of the follow-up period, whereas it was unchanged in treated patients. In conclusion, beta blockers prevent RV remodeling, with a concomitant improvement in exercise tolerance in patients with complete transposition of the great arteries and systemic RV dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317376     DOI: 10.1016/j.amjcard.2006.10.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

1.  Heart failure in adult congenital heart disease.

Authors:  Ada Stefanescu; Doreen DeFaria Yeh; David M Dudzinski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-09

Review 2.  Management of Heart Failure in Adult Congenital Heart Disease.

Authors:  Aarthi Sabanayagam; Omer Cavus; Jordan Williams; Elisa Bradley
Journal:  Heart Fail Clin       Date:  2018-08-20       Impact factor: 3.179

3.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions.

Authors:  Candice K Silversides; Omid Salehian; Erwin Oechslin; Markus Schwerzmann; Isabelle Vonder Muhll; Paul Khairy; Eric Horlick; Mike Landzberg; Folkert Meijboom; Carole Warnes; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

Review 4.  Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations.

Authors:  Anastacia M Garcia; Jonathan-Thomas Beatty; Stephanie J Nakano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-28       Impact factor: 4.733

Review 5.  Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease.

Authors:  Craig S Broberg; Luke J Burchill
Journal:  Int J Cardiol       Date:  2015-04-10       Impact factor: 4.164

Review 6.  Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.

Authors:  Werner Budts; Jolien Roos-Hesselink; Tanja Rädle-Hurst; Andreas Eicken; Theresa A McDonagh; Ekaterini Lambrinou; Maria G Crespo-Leiro; Fiona Walker; Alexandra A Frogoudaki
Journal:  Eur Heart J       Date:  2016-01-18       Impact factor: 29.983

Review 7.  Heart failure in congenital heart disease: the role of genes and hemodynamics.

Authors:  Rachel D Vanderlaan; Christopher A Caldarone; Peter H Backx
Journal:  Pflugers Arch       Date:  2014-02-01       Impact factor: 3.657

8.  Role of β-blocker therapy in pediatric heart failure.

Authors:  Akash R Patel; Robert E Shaddy
Journal:  Ped Health       Date:  2010

9.  The Right Heart in Congenital Heart Disease, Mechanisms and Recent Advances.

Authors:  Julien Guihaire; François Haddad; Olaf Mercier; Daniel J Murphy; Joseph C Wu; Elie Fadel
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15

Review 10.  Managing Heart Failure in Transposition of the Great Arteries.

Authors:  Sangeeta Shah; Tripti Gupta; Raza Ahmad
Journal:  Ochsner J       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.